|
Clinical implications of germline genetic testing stratified by ethnicity in a large colorectal cancer cohort. |
|
|
|
Stock and Other Ownership Interests - InVitae |
Consulting or Advisory Role - InVitae |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Invitae |
|
|
Other Relationship - Janssen, Immunovia, Epigenomics, Guardant, Freenome, Universal diagnostics |
(OPTIONAL) Uncompensated Relationships - Invitae, Ambry, GeneDx |
|
|
|
Stock and Other Ownership Interests - Invitae |